Jennifer Kathleen Bielasz

Jennifer Kathleen Bielasz discloses dealings in Arena Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 1 February 2012 to 29 March 2012, the count stands at 4 filings.

On the open market, the record shows 1 purchase worth €44 and 2 sales worth €25k. Netting one side against the other leaves €25k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise.

The latest filing, published on 30 March 2012, reports an option exercise of €6,995 in Arena Pharmaceuticals Inc. The clock since the last published purchase (7 February 2012) now reads 5,389 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.